http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/ Using Rapidminer to model trends in the financial markets Mon, 06 Oct 2008 20:55:31 +0000 http://wordpress.org/?v=2.6.2 http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-2274 Tom Sun, 03 Aug 2008 11:09:37 +0000 http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-2274 Bob: Too bad for you! :) Bob: Too bad for you!

]]> http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-2272 BOB NEWHART Sat, 02 Aug 2008 20:46:29 +0000 http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-2272 WOW, I HAVE NOTICED 12" IN REDUCTION IN MY PENIS SIZE SINCE I STOPPED TAKING THIS DRUG. WOW, I HAVE NOTICED 12″ IN REDUCTION IN MY PENIS SIZE SINCE I STOPPED TAKING THIS DRUG.

]]> http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-1056 Tom Sun, 30 Dec 2007 12:12:16 +0000 http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-1056 Richard: Thanks for the info, its comforting to know. Still, I would know conclusively until more there is more testing done on me. It could just be something completely else. Richard: Thanks for the info, its comforting to know. Still, I would know conclusively until more there is more testing done on me. It could just be something completely else.

]]> http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-1051 Richard Stack Sun, 30 Dec 2007 07:23:10 +0000 http://www.neuralmarkettrends.com/2007/12/29/i-stopped-taking-resveratrol/#comment-1051 No major side effects from Resveratrol at high dosages. The red grape constituent resveratrol possesses cancer chemopreventive properties in rodents. The hypothesis was tested that, in healthy humans, p.o. administration of resveratrol is safe and results in measurable plasma levels of resveratrol. A phase I study of oral resveratrol (single doses of 0.5, 1, 2.5, or 5 g) was conducted in 10 healthy volunteers per dose level. Resveratrol and its metabolites were identified in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry and quantitated by high-performance liquid chromatography-UV. Consumption of resveratrol did not cause serious adverse events. Resveratrol and six metabolites were recovered from plasma and urine. Peak plasma levels of resveratrol at the highest dose were 539 ± 384 ng/mL (2.4 µmol/L, mean ± SD; n No major side effects from Resveratrol at high dosages. The red grape constituent resveratrol possesses cancer chemopreventive properties in rodents. The hypothesis was tested that, in healthy humans, p.o. administration of resveratrol is safe and results in measurable plasma levels of resveratrol. A phase I study of oral resveratrol (single doses of 0.5, 1, 2.5, or 5 g) was conducted in 10 healthy volunteers per dose level. Resveratrol and its metabolites were identified in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry and quantitated by high-performance liquid chromatography-UV. Consumption of resveratrol did not cause serious adverse events. Resveratrol and six metabolites were recovered from plasma and urine. Peak plasma levels of resveratrol at the highest dose were 539 ± 384 ng/mL (2.4 µmol/L, mean ± SD; n

]]>